Volume 4 Supplement 1
Exploring pleiotropy using principal components
- Jeannette T Bensen†1Email author,
- Leslie A Lange†2,
- Carl D Langefeld2,
- Bao-Li Chang1,
- Eugene R Bleecker1,
- Deborah A Meyers1 and
- Jianfeng Xu1, 2
© Bensen et al; licensee BioMed Central Ltd 2003
Published: 31 December 2003
A standard multivariate principal components (PCs) method was utilized to identify clusters of variables that may be controlled by a common gene or genes (pleiotropy). Heritability estimates were obtained and linkage analyses performed on six individual traits (total cholesterol (Chol), high and low density lipoproteins, triglycerides (TG), body mass index (BMI), and systolic blood pressure (SBP)) and on each PC to compare our ability to identify major gene effects. Using the simulated data from Genetic Analysis Workshop 13 (Cohort 1 and 2 data for year 11), the quantitative traits were first adjusted for age, sex, and smoking (cigarettes per day). Adjusted variables were standardized and PCs calculated followed by orthogonal transformation (varimax rotation). Rotated PCs were then subjected to heritability and quantitative multipoint linkage analysis. The first three PCs explained 73% of the total phenotypic variance. Heritability estimates were above 0.60 for all three PCs. We performed linkage analyses on the PCs as well as the individual traits. The majority of pleiotropic and trait-specific genes were not identified. Standard PCs analysis methods did not facilitate the identification of pleiotropic genes affecting the six traits examined in the simulated data set. In addition, genes contributing 20% of the variance in traits with over 0.60 heritability estimates could not be identified in this simulated data set using traditional quantitative trait linkage analyses. Lack of identification of pleiotropic and trait-specific genes in some cases may reflect their low contribution to the traits/PCs examined or more importantly, characteristics of the sample group analyzed, and not simply a failure of the PC approach itself.
Keywordsmultivariate analysis principle components quantitative traits heritability estimates linkage
Principal component analyses often provide valuable information that allows data reduction and reveals relationships between variables that were not previously suspected. As we begin to better understand the scope of gene effects, we find that single genes often contribute to multiple phenotypes (pleiotropy). Therefore, when mapping genes for complex disorders, it can be helpful to identify groups of variables or phenotypes (principal components) that may be controlled by a single gene. Arya et al.  demonstrated the practical application of principal component analysis by evaluating eight insulin resistance syndrome-related phenotypes in 27 nondiabetic Mexican-American extended families . In their analyses, they identified three principal components factors and following multipoint variance components linkage analyses, their adiposity-insulin factor showed linkage at two different regions on chromosome 6q with LOD scores > 4.1. This observation was consistent with their previous finding of a major susceptibility locus for insulin resistance on chromosome 6q, which has been shown to have strong pleiotropic effects on other insulin resistance syndrome-related phenotypes such as body mass index (BMI) and leptin levels [1, 2]. To examine this type of pleiotropic gene effect seen in the Arya study, we chose to evaluate the use of standard principal components (PC) methods to capture this effect in the Genetic Analysis Workshop (GAW13) simulated data set. Our first objective was to assess whether the traits grouped together in one of the PCs in our data analysis actually correspond to traits that share common gene effects in the underlying GAW13 simulated genetic model, our second objective was to identify the heritability of these PCs, and our third objective was to identify major pleiotropic genes through linkage analysis.
All analyses were performed on the simulated data without missing observations. Replicate data set 57 was randomly selected and analysis was limited to the year 11 time point. Year 11 was selected because this was the first year in which Cohorts 1 and 2 both had data collected. Observations with triglyceride values greater than 400 (n = 27) were excluded in order to obtain valid low density lipoprotein (LDL) calculations. In addition, several (n = 8 > 4 SD) observations were excluded because they were judged to be highly influential in the PC analysis.
Principal component trait loading values (rotated values).
Heritability estimation and quantitative multipoint linkage analysis were performed on the PCs and on the residuals for individual QTs using variance-component methodology, as implemented in the Sequential Oligogenic Linkage Analysis Routines (SOLAR) . Genotype data provided from all individuals were used to generate multipoint identity-by-descent (IBD) estimates throughout the genome. Phenotypic traits examined included the PCs and the raw QTs. No additional covariate adjustment was made at this stage. All analyses were performed a second time, with additional adjustment for cohort effect (using an indicator variable) when residuals were obtained. This was done in order to examine whether cohort had an effect after adjusting for age.
We did not consult the GAW13 simulated data set answers prior to either the interpretation of the PCs or performing linkage analysis. Verification of genes modeled in the simulated data set at baseline (not those influencing longitudinal data) were considered verified if linkage analysis identified a marker with a peak LOD score (LOD > 1.0) within 20 cM of the gender-averaged chromosomal location for a simulated trait gene. While there is little consensus regarding the most appropriate LOD score threshold for complex disease, similar to other studies of complex disease reporting LODs less than 2.0, we considered LOD scores greater than 1.0 as suggestive evidence of linkage [5, 6].
At year 11 we had complete data on 989 individuals (316 families) from Cohort 1, mean age 59.9 years, and 1511 individuals (330 families) in Cohort 2, mean age 53.4. Variable means for the QTs and confounders were comparable between cohorts, except for SBP, TGs, and cigarettes per day, where mean SBP and TG were higher in Cohort 1 than 2 (SBP: 137 vs. 130 and TG: 146 vs. 136, respectively) and mean cigarettes per day were lower in Cohort 1 than 2 (4 vs. 6, respectively). After adjustment for age, sex, and cigarettes per day, cohort was a statistically significant predictor of only one of the QTs: SBP. The additional adjustment for cohort produced results (PCs and linkage) that were similar to those reported and did not change any of our conclusions.
Variance and heritability estimates for individual traits and principal components.
1/2 (Log Chol + LDL)
1/2 BMI + (Log TG - HDL)
Log SBP + 2/3 BMI
Genome-wide linkage results for principal components.
- - -
No LOD > 1.0
- - -
No LOD > 1.0
b10 @ 124 (height)
Genome-wide linkage results for individual traits.
- - -
No LOD > 1.0
- - -
No LOD > 1.0
- - -
No LOD > 1.0
No LOD > 1.0
b30 @66 (Chol) b21 @45 (HDL)
b11 @70 (Weight)
Unblinded major pleiotropic genes influencing TG and HDL-linkage results.
1/2 (Log Chol + LDL)
PC 2 1/2 BMI + (Log TG - HDL)
PC 3 Log SBP + 2/3 BMI
Pleiotropic effects are a common phenomenon in reported studies of complex disease. Methods are needed to identify pleiotropic genes that may contribute differing amounts to the variances of multiple phenotypes. To this end, we chose to evaluate our ability to identify such genes by PC analysis, followed by heritability estimates and linkage analysis.
While our analysis was somewhat limited in terms of the number of variables available in the complete data set, PC analysis of the six variables identified three primary PCs explaining 79% of the phenotypic variance. Covariates (age, gender, and smoking) were adjusted prior to PC analysis, consistent with the strategy used by Moser et al., although concerns about the effect of these adjustments on PC and heritability estimates arose . We therefore performed covariate adjustments before and after PC analysis [data not shown] and found no significant differences in PCs, loading, or heritability. Overall, the PC analysis, in particular PC2, reflected the pleiotropic genes (HDL and TG) modeled in the simulated data.
Heritability estimates were statistically significant for each of the three major PCs, as were those for the traits evaluated individually. Each PC heritability estimate was consistent in magnitude with the trait heritabilities comprising the PC. PC2, which reflected the simulated model best with respect to shared gene effects, had a heritability estimate slightly higher than the two individual variables (HDL and TG) in the PC and closer to that for BMI alone. This higher heritability estimate for PC2 may reflect the accuracy with which PC identifies/groups variables with common genetic influence or it may reflect the significant influence of BMI on this PC.
Several factors that may have contributed to limited power in both our individual trait and PC linkage analyses include sample size and composition (single replicate), pedigree structure, and the number and size of genetic effects. One of the challenges facing linkage mapping for complex disease traits is adequate sample size. Risch and Merikangas state that the power of linkage for complex disease is limited to the detection of only the strongest loci unless thousands of small families are utilized . In this report a total of 646 families were analyzed and thus may not have provided ample power for the detection of genes contributing modestly to trait variance. The analysis of a single replicate in the GAW13 simulated data set may also have hindered our ability to detect meaningful linkage.
Studies have shown the PC approach may improve the power to identify genes with pleiotropic effects involved in complex disease [1, 9, 10]. While PC heritability estimates were encouraging, we were unable to identify pleiotropic genes. One very plausible explanation may be that rather than a single gene with a major effect, the high heritability reflected many genes with small effects. While it has been shown that the PC approach has greater power to detect major pleiotropic genes , the power to detect genes with small effects is likely to be limited. In addition, our investigation was highly dependent on the extent of pleiotropy modeled in the simulated data set as well as our selection of variables for analysis. HDL, TG, and glucose were modeled as pleiotropic traits; however our investigation only considered HDL and TG (major components of our PC2). Ideally, PC2 would have identified at least the b12 gene contributing 20% and 10% to the variance of HDL and TG, respectively. Several investigators have demonstrated increased power and precision in identifying genetic effects when using multivariate approaches for correlated traits [11, 12]. However, in a recent commentary, Meigs points out that the results of such analyses can be influenced by both the number and nature of variables included in the model . The lack of our ability to identify the b12 gene in this simulated data set may have been due to the omission of glucose from our model or may reflect the difficulty our method has in identifying complex trait genes. Finally, while we utilized the standard PC method and adjusted for covariates prior to linkage analysis to maximize power, we may have missed potentially important genetic effects by focusing first on the PCs that explained the majority of phenotypic variation.
In summary, PC analysis has been demonstrated in reported studies of complex disease to localize regions of the human genome likely to contain pleiotropic genes , but may be influenced by factors such as the number and effect size of pleiotropic genes involved as well as complex trait variables available for inclusion in the PC analysis. Further studies are needed to assess the utility of the PC approach in complex disease.
The Framingham Heart Study is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with Boston University. This manuscript was not prepared in collaboration with investigators of the Framingham Heart Study and does not necessarily reflect the opinions or views of the Framingham Heart Study, Boston University, or NHLBI.
- Arya R, Blangero J, Williams K, Almasy L, Dyer TD, Leach RJ, O'Connell P, Stern MP, Duggirala R: Factors of insulin resistance syndrome-related phenotypes are linked to genetic locations on chromosomes 6 and 7 in nondiabetic Mexican-Americans. Diabetes. 2002, 51: 841-847. 10.2337/diabetes.51.3.841.View ArticlePubMedGoogle Scholar
- Duggirala R, Blangero J, Almasy L, Arya R, Dyer TD, Williams K, Leach RJ, O'Connell P, Stern MP: A major locus for fasting insulin concentrations and insulin resistance on chromosome 6q with strong pleiotropic effects on obesity-related phenotypes in non-diabetic Mexican-Americans. Am J Hum Genet. 2001, 68: 1149-1164. 10.1086/320100.PubMed CentralView ArticlePubMedGoogle Scholar
- Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972, 18: 499-502.PubMedGoogle Scholar
- Almasy L, Blangero J: Multipoint quantitative trait linkage analysis in general pedigrees. Am J Hum Genet. 1998, 62: 1198-1211. 10.1086/301844.PubMed CentralView ArticlePubMedGoogle Scholar
- Silverman EK, Palmer LJ, Mosley JD, Barth M, Senter JM, Brown A, Drazen JM, Kwiatkowski DJ, Chapman HA, Campbell EJ, Province MA, Rao DC, Reilly JJ, Ginns LC, Speizer FE, Weiss ST: Genomewide linkage analysis of quantitative spirometric phenotypes in severe early-onset chronic obstructive pulmonary disease. Am J Hum Genet. 2002, 70: 1229-1239. 10.1086/340316.PubMed CentralView ArticlePubMedGoogle Scholar
- Angius A, Petretto E, Maestrale GB, Forabosco P, Casu G, Piras D, Fanciulli M, Falchi M, Melis PM, Palermo M, Pirastu M: A new essential hypertension susceptibility locus on chromosome 2p24-p25, detected by genomewide search. Am J Hum Genet. 2002, 71: 893-905. 10.1086/342929.PubMed CentralView ArticlePubMedGoogle Scholar
- Moser KL, Jedrey CM, Conti D, Schick JH, Gray-McGuire C, Nath SK, Daley D, Olson JM: Comparison of three methods for obtaining principal components from family data in genetic analysis of complex disease. Genet Epidemiol. 2002, 21 (suppl 1): S726-S731.Google Scholar
- Risch N, Merikangas K: The future of genetic studies of complex human diseases. Science. 1996, 273: 1516-1517. 10.1126/science.273.5281.1516.View ArticlePubMedGoogle Scholar
- Morton NE, Matsuura J, Bart R, Lew R: Genetic epidemiology of an institutionalized cohort of mental retardates. Clin Genet. 1978, 13: 449-461.View ArticlePubMedGoogle Scholar
- Ott J, Rabinowitz D: A principal-components approach based on heritability for combining phenotype information. Hum Hered. 1999, 49: 106-111. 10.1159/000022854.View ArticlePubMedGoogle Scholar
- Amos CI, de Andrade M, Shu D: Comparison of multivariate tests for genetic linkage. Hum Hered. 2001, 51: 133-144. 10.1159/000053334.View ArticlePubMedGoogle Scholar
- Evans DM: The power of multivariate quantitative-trait loci linkage analysis is influenced by the correlation between the variables. Am J Hum Genet. 2002, 70: 1599-1602. 10.1086/340850.PubMed CentralView ArticlePubMedGoogle Scholar
- Meigs JB: Invited commentary: Insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors. Am J Epidemiol. 2000, 152: 908-911. 10.1093/aje/152.10.908.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.